Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


Acrobot secures £2.6 million investment in equity financing round
New investment will help Acrobot develop more effective computer-assisted surgical tools

LONDON, UK, 30 July 2007 – The Acrobot Company Limited (Acrobot), the computer-assisted surgery specialists, announced today that it has closed on a £2.6 million equity financing round. The investment was made by a syndicate co-led by London Technology Fund and PUK Ventures and included Imperial Innovations Group plc.

The company is now poised to move forward to full commercialisation of its Planner and Navigation technologies and will further develop its ‘active constraint’ technology for robotic applications. The Acrobot® Navigation system has been developed by Acrobot in collaboration with Corin Group PLC (Corin) to enable accurate implantation of Corin’s lead product – the Cormet® metal on metal hip resurfacing implant. Many orthopaedic surgeons are now using Acrobot’s products enabling them to plan and perform hip resurfacing surgery more accurately.

The overall goal of Acrobot’s technologies is to provide speed, accuracy and reproducibility, which will ultimately lead to minimally-invasive, bone-conserving, orthopaedic surgery.

Acrobot has developed and clinically proven a range of products in three key areas related to orthopaedic surgery: computer-assisted 3D planning, surgical navigation and surgeon-controlled robotic surgery. Acrobot® Planner creates a pre-operative plan, according to which the bone is prepared and the implant positioned using Acrobot’s unique surgical navigation system, Acrobot® Navigation, which tracks the position of surgical instruments relative to the patient to ensure highly accurate surgery. In the third area, Acrobot’s key ‘active constraint’ technology confines a bone cutting tool to a defined volume in space, allowing the surgeon to shape the bone to receive a joint replacement implant. This simple, universally applicable, surgeon-controlled robotic solution would replace conventional instrumentation, enabling better bone preparation and more accurate implant positioning.

Commenting on the fundraising, Graeme Brookes, CEO of Acrobot, said: “We are delighted to welcome our new investors; their understanding of fast growing high technology companies played an essential part in facilitating this fundraising. We now have the resources necessary to take our exciting developments to market and to further develop key next generation robotic tools that engage the orthopaedic surgeon. We are very excited to have reached this important milestone in the evolution of our business”.

Contact details:

At Northbank Communications
Tony Stephenson, Account Manager
Holly Griffiths, Account Executive
Tristan Jervis, Account Director

At Acrobot
Graeme Brookes, CEO
Paula Gomes, Director of Operations

Northbank Communications
+44 (0) 20 7268 3002

The Acrobot Company Ltd
+44 (0) 20 7403 5866
Unit 13.3.2 The Leathermarket
Weston Street
London SE1 3ER

Publisher Contact Information:

The Acrobot Company
+44 (0) 20 7403 5866

Company profile of Acrobot
Past press releases of Acrobot.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Feb 14€19.0MBiopharmaceuticals
Feb 14N/AInternet services
Feb 14€4.6MBusiness applications
Feb 13€13.0MBiopharmaceuticals
Feb 13€25.0MMedical devices
Feb 13€15.0MBusiness applications

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.